These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 20387011)
21. Anti-Saccaromyces Cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease ASCA in autoimmune thyroid disease. Yazıcı D; Aydın SZ; Yavuz D; Tarçın O; Deyneli O; Direskeneli H; Akalın S Endocrine; 2010 Oct; 38(2):194-8. PubMed ID: 21046480 [TBL] [Abstract][Full Text] [Related]
22. Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19. Melayah S; Mankaï A; Jemni M; Chaben AB; Ghozzi M; Ben Abdelkrim A; Ach K; Ghariani N; Denguezli M; Benzarti W; Benzarti M; Melayah S; Naija W; Ghedira I Arab J Gastroenterol; 2022 Nov; 23(4):241-245. PubMed ID: 36351870 [TBL] [Abstract][Full Text] [Related]
23. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease. El-Matary W; Dupuis K; Sokoro A Acta Paediatr; 2015 Aug; 104(8):827-30. PubMed ID: 25877674 [TBL] [Abstract][Full Text] [Related]
24. Frequency of ASCA seropositivity in children with cystic fibrosis. Condino AA; Hoffenberg EJ; Accurso F; Penvari C; Anthony M; Gralla J; O'Connor JA J Pediatr Gastroenterol Nutr; 2005 Jul; 41(1):23-6. PubMed ID: 15990625 [TBL] [Abstract][Full Text] [Related]
25. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695 [TBL] [Abstract][Full Text] [Related]
26. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Harrer M; Reinisch W; Dejaco C; Kratzer V; Gmeiner M; Miehsler W; Norman GL; Gangl A; Vogelsang H Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1281-5. PubMed ID: 14624150 [TBL] [Abstract][Full Text] [Related]
27. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease]. Le Goff C; Chapelle JP; Lutteri L Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604 [TBL] [Abstract][Full Text] [Related]
28. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment. Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572 [TBL] [Abstract][Full Text] [Related]
29. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease. Duarte-Silva M; Afonso PC; de Souza PR; Peghini BC; Rodrigues-Júnior V; de Barros Cardoso CR Autoimmunity; 2019 Feb; 52(1):37-47. PubMed ID: 30884988 [TBL] [Abstract][Full Text] [Related]
31. Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease. Van Kemseke C; Belaïche J; Steeman C; Louis E Acta Gastroenterol Belg; 2003; 66(1):1-6. PubMed ID: 12812142 [TBL] [Abstract][Full Text] [Related]
33. Anti-Saccharomyces cerevisiae Antibodies as a Prognostic Biomarker in Children With Crohn Disease. Chandrakumar A; Georgy M; Agarwal P; 't Jong GW; El-Matary W J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):82-87. PubMed ID: 30789863 [TBL] [Abstract][Full Text] [Related]
34. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease. Jaskowski TD; Litwin CM; Hill HR Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease. Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]